<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <committees>
      <billCommittees>
        <item>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-06-08T20:14:19Z</date>
            </item>
          </activities>
          <chamber>Senate</chamber>
          <systemCode>ssju00</systemCode>
          <name>Judiciary Committee</name>
          <type>Standing</type>
          <subcommittees />
        </item>
      </billCommittees>
    </committees>
    <actions>
      <item>
        <actionDate>2017-06-08</actionDate>
        <committee>
          <systemCode>ssju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on the Judiciary.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <committee />
        <actionDate>2017-06-08</actionDate>
        <links />
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
      <actionTypeCounts>
        <referredToCommittee>1</referredToCommittee>
        <introducedInSenate>1</introducedInSenate>
      </actionTypeCounts>
    </actions>
    <recordedVotes />
    <laws />
    <calendarNumbers />
    <titles>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <title>SITSA Act</title>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <title>Stop the Importation and Trafficking of Synthetic Analogues Act of 2017</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <title>A bill to amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated, and for other purposes.</title>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <title>SITSA Act</title>
      </item>
      <item>
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <title>Stop the Importation and Trafficking of Synthetic Analogues Act of 2017</title>
      </item>
    </titles>
    <cosponsors>
      <item>
        <fullName>Sen. Feinstein, Dianne [D-CA]</fullName>
        <party>D</party>
        <bioguideId>F000062</bioguideId>
        <identifiers>
          <lisID>1332</lisID>
          <bioguideId>F000062</bioguideId>
          <gpoId>8338</gpoId>
        </identifiers>
        <lastName>FEINSTEIN</lastName>
        <sponsorshipDate>2017-06-08</sponsorshipDate>
        <middleName />
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <firstName>DIANNE</firstName>
        <state>CA</state>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <fullName>Sen. Johnson, Ron [R-WI]</fullName>
        <party>R</party>
        <bioguideId>J000293</bioguideId>
        <identifiers>
          <lisID>2086</lisID>
          <gpoId>8355</gpoId>
          <bioguideId>J000293</bioguideId>
        </identifiers>
        <lastName>Johnson</lastName>
        <sponsorshipDate>2017-07-17</sponsorshipDate>
        <middleName />
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <firstName>Ron</firstName>
        <state>WI</state>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <fullName>Sen. Klobuchar, Amy [D-MN]</fullName>
        <party>D</party>
        <bioguideId>K000367</bioguideId>
        <identifiers>
          <bioguideId>K000367</bioguideId>
          <lisID>1826</lisID>
          <gpoId>8249</gpoId>
        </identifiers>
        <lastName>Klobuchar</lastName>
        <sponsorshipDate>2017-07-17</sponsorshipDate>
        <middleName />
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <firstName>Amy</firstName>
        <state>MN</state>
        <sponsorshipWithdrawnDate />
      </item>
    </cosponsors>
    <cboCostEstimates />
    <latestAction>
      <text>Read twice and referred to the Committee on the Judiciary.</text>
      <links />
      <actionDate>2017-06-08</actionDate>
    </latestAction>
    <updateDate>2018-08-28T20:28:01Z</updateDate>
    <version>1.0.0</version>
    <policyArea>
      <name>Crime and Law Enforcement</name>
    </policyArea>
    <billType>S</billType>
    <billNumber>1327</billNumber>
    <originChamber>Senate</originChamber>
    <relatedBills>
      <item>
        <type>HR</type>
        <latestTitle>SITSA Act</latestTitle>
        <congress>115</congress>
        <latestAction>
          <text>Received in the Senate and Read twice and referred to the Committee on the Judiciary.</text>
          <actionDate>2018-06-18</actionDate>
        </latestAction>
        <number>2851</number>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <type>HR</type>
        <latestTitle>Opioid Emergency Response Act</latestTitle>
        <congress>115</congress>
        <latestAction>
          <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
          <actionDate>2018-05-22</actionDate>
        </latestAction>
        <number>5531</number>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <title>SITSA Act</title>
    <congress>115</congress>
    <summaries>
      <billSummaries>
        <item>
          <actionDesc>Introduced in Senate</actionDesc>
          <actionDate>2017-06-08</actionDate>
          <lastSummaryUpdateDate>2018-08-10T14:52:40Z</lastSummaryUpdateDate>
          <name>Introduced in Senate</name>
          <text><![CDATA[<p><b>Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 or the SITSA Act</b></p> <p>This bill amends the Controlled Substances Act to establish a new, sixth schedule of controlled substances&#8212;schedule A. A drug or substance in schedule A has a chemical structure that is similar to, and an effect on the body that is similar to or greater than, a controlled substance in schedule I, II, III, IV, or V.</p> <p>The bill adds 13 synthetic fentanyl-related substances to schedule A. It also authorizes, and establishes procedures for, the Drug Enforcement Administration (DEA) to temporarily and permanently place a drug or substance in schedule A. </p> <p>The bill establishes criminal penalties for an individual who imports, exports, manufactures, distributes, or possesses with intent to distribute a schedule A substance. However, it explicitly prohibits criminal and civil penalties solely for possession of a schedule A controlled substance. </p> <p>The bill makes it unlawful to import, export, manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense, a schedule A substance that is not clearly labeled.</p> <p>Finally, it establishes new, separate DEA registration requirements for manufacturers, distributors, and importers and exporters of schedule A substances. </p>]]></text>
          <versionCode>00</versionCode>
          <updateDate>2017-06-08T04:00:00Z</updateDate>
        </item>
      </billSummaries>
    </summaries>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Criminal procedure and sentencing</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Fraud offenses and financial crimes</name>
          </item>
          <item>
            <name>Licensing and registrations</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Crime and Law Enforcement</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <committeeReports />
    <introducedDate>2017-06-08</introducedDate>
    <sponsors>
      <item>
        <bioguideId>G000386</bioguideId>
        <middleName>ERNEST</middleName>
        <byRequestType />
        <fullName>Sen. Grassley, Chuck [R-IA]</fullName>
        <lastName>GRASSLEY</lastName>
        <state>IA</state>
        <party>R</party>
        <identifiers>
          <lisID>457</lisID>
          <bioguideId>G000386</bioguideId>
          <gpoId>8316</gpoId>
        </identifiers>
        <firstName>CHARLES</firstName>
      </item>
    </sponsors>
    <notes />
    <createDate>2017-06-09T00:26:37Z</createDate>
    <amendments />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

